{"title":"A hybrid M-DbneAlexnet for brain tumour detection using MRI images.","authors":"Jayasri Kotti, Vidyadhari Chalasani, Creesy Rajan","doi":"10.1080/13813455.2025.2531118","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Brain Tumour (BT) is characterised by the uncontrolled proliferation of the cells within the brain which can result in cancer. Detecting BT at the early stage significantly increases the patient's survival chances. The existing BT detection methods often struggle with high computational complexity, limited feature discrimination, and poor generalisation.</p><p><strong>Methods: </strong>To mitigate these issues, an effective brain tumour detection and segmentation method based on A hybrid network named MobileNet- Deep Batch-Normalized eLU AlexNet (M-DbneAlexnet) is developed based on Magnetic Resonance Imaging (MRI). The image enhancement is done by Piecewise Linear Transformation (PLT) function. BT region is segmented Transformer Brain Tumour Segmentation (TransBTSV2). Then feature extraction is done. Finally, BT is detected using M-DbneAlexnet model, which is devised by combining MobileNet and Deep Batch-Normalized eLU AlexNet (DbneAlexnet).<b>Results:</b> The proposed model achieved an accuracy of 92.68%, sensitivity of 93.02%, and specificity of 92.85%, demonstrating its effectiveness in accurately detecting brain tumors from MRI images.</p><p><strong>Discussion: </strong>The proposed model enhances training speed and performs well on limited datasets, making it effective for distinguishing between tumor and healthy tissues. Its practical utility lies in enabling early detection and diagnosis of brain tumors, which can significantly reduce mortality rates.</p>","PeriodicalId":8331,"journal":{"name":"Archives of Physiology and Biochemistry","volume":" ","pages":"1-21"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Physiology and Biochemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13813455.2025.2531118","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Brain Tumour (BT) is characterised by the uncontrolled proliferation of the cells within the brain which can result in cancer. Detecting BT at the early stage significantly increases the patient's survival chances. The existing BT detection methods often struggle with high computational complexity, limited feature discrimination, and poor generalisation.
Methods: To mitigate these issues, an effective brain tumour detection and segmentation method based on A hybrid network named MobileNet- Deep Batch-Normalized eLU AlexNet (M-DbneAlexnet) is developed based on Magnetic Resonance Imaging (MRI). The image enhancement is done by Piecewise Linear Transformation (PLT) function. BT region is segmented Transformer Brain Tumour Segmentation (TransBTSV2). Then feature extraction is done. Finally, BT is detected using M-DbneAlexnet model, which is devised by combining MobileNet and Deep Batch-Normalized eLU AlexNet (DbneAlexnet).Results: The proposed model achieved an accuracy of 92.68%, sensitivity of 93.02%, and specificity of 92.85%, demonstrating its effectiveness in accurately detecting brain tumors from MRI images.
Discussion: The proposed model enhances training speed and performs well on limited datasets, making it effective for distinguishing between tumor and healthy tissues. Its practical utility lies in enabling early detection and diagnosis of brain tumors, which can significantly reduce mortality rates.
期刊介绍:
Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.
The scope encompasses all topics related to the molecular and cellular pathophysiology of metabolic diseases like obesity, type 2 diabetes and the metabolic syndrome, and their associated complications.
Clinical studies are considered as an integral part of the Journal and should be related to one of the following topics:
-Dysregulation of hormone receptors and signal transduction
-Contribution of gene variants and gene regulatory processes
-Impairment of intermediary metabolism at the cellular level
-Secretion and metabolism of peptides and other factors that mediate cellular crosstalk
-Therapeutic strategies for managing metabolic diseases
Special issues dedicated to topics in the field will be published regularly.